Showing results (911-920 of 999) with videos related to

Sort By:
Pageof 100
Circulation|November 12, 2019
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort AnalysisAmbarish Pandey, Kershaw V Patel, Wanpen Vongpatanasin, et al.
Journal of Clinical Lipidology|October 11, 2011
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialistsMichael H Davidson, Christie M Ballantyne, Terry A Jacobson, et al.
American Heart Journal|March 1, 2014
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registryEmily C O'Brien, Matthew T Roe, Elizabeth S Fraulo, et al.
Circulation|April 13, 2021
Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort AnalysisMatthew W Segar, Byron C Jaeger, Kershaw V Patel, et al.
European Journal of Preventive Cardiology|September 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-ITChen Gurevitz, Deepak L Bhatt, Robert P Giugliano, et al.
Gut|February 16, 2024
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosisHashem El-Serag, Fasiha Kanwal, Jing Ning, et al.
Circulation|October 28, 2021
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABGSubodh Verma, Deepak L Bhatt, Ph Gabriel Steg, et al.
JACC. Heart Failure|May 16, 2024
Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort AnalysisAmbarish Pandey, Kershaw V Patel, Matthew W Segar, et al.
Science (New York, N.Y.)|November 15, 2008
Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitmentEun Young Choi, Emmanouil Chavakis, Marcus A Czabanka, et al.
Circulation|April 15, 2009
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart AssociationMark A Hlatky, Philip Greenland, Donna K Arnett, et al.
Pageof 100